XGN
Exagen Inc
Price:  
8.17 
USD
Volume:  
617,265.00
United States | Health Care Providers & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

XGN EV/EBITDA

-184.3%
Upside

As of 2026-10-05, the EV/EBITDA ratio of Exagen Inc (XGN) is -11.04. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. XGN's latest enterprise value is 125.70 mil USD. XGN's TTM EBITDA according to its financial statements is -11.38 mil USD. Dividing these 2 quantities gives us the above XGN EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 8.6x - 9.3x 9.1x
Forward P/E multiples 8.5x - 10.4x 9.2x
Fair Price (6.46) - (6.97) (6.89)
Upside -179.1% - -185.3% -184.3%
8.17 USD
Stock Price
(6.89) USD
Fair Price

XGN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-09-30 -10.99
2026-09-29 -11.22
2026-09-28 -11.46
2026-09-25 -11.78
2026-09-24 -11.81
2026-09-23 -11.55
2026-09-22 -11.81
2026-09-21 -11.65
2026-09-18 -11.36
2026-09-17 -10.64
2026-09-16 -10.52
2026-09-15 -10.13
2026-09-14 -9.94
2026-09-11 -9.51
2026-09-10 -9.43
2026-09-09 -9.89
2026-09-08 -9.87
2026-09-04 -10.25
2026-09-03 -10.20
2026-09-02 -10.16
2026-09-01 -9.63
2026-08-31 -9.93
2026-08-28 -10.00
2026-08-27 -10.17
2026-08-26 -10.37
2026-08-25 -10.28
2026-08-24 -10.34
2026-08-21 -10.71
2026-08-20 -10.52
2026-08-19 -10.05
2026-08-18 -8.92
2026-08-17 -9.07
2026-08-14 -9.02
2026-08-13 -8.91
2026-08-12 -8.92
2026-08-11 -9.16
2026-08-10 -8.99
2026-08-07 -9.30
2026-08-06 -8.92
2026-08-05 -9.00
2026-08-04 -8.73
2026-08-03 -6.36
2026-07-31 -6.16
2026-07-30 -6.35
2026-07-29 -5.92
2026-07-28 -6.05
2026-07-27 -5.99
2026-07-24 -6.36
2026-07-23 -6.72
2026-07-22 -6.71